The effect of liver metastasis on efficacy of immunotherapy plus chemotherapy in advanced lung cancerBao‐Dong Qin, Yuan‐Sheng Zang, Xi He et al.|Critical Reviews in Oncology/Hematology|2020Cited by 71
The effectiveness of afatinib and osimertinib in a Chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V): a case report and literature reviewBao‐Dong Qin, Yuan‐Sheng Zang, Xiao‐Dong Jiao et al.|OncoTargets and Therapy|2018Cited by 33
Molecular mechanism of triple‑negative breast cancer‑associated BRCA1 and the identification of signaling pathwaysQi Feng, Yuan‐Sheng Zang|Oncology Letters|2019Cited by 31
Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8+T cellsBiaolong Yang, Yuan‐Sheng Zang|Cellular Oncology|2022Cited by 18